Roger Pfeiffer, DO
Gynecologic Oncology · Owasso, OKNPI 1215054622
Payments from drug & device makers
What this record shows
This record is dominated by education: $4,500 of the $6,906 with a category attached, or 65.2%. Intuitive Surgical accounts for 84.7% of it on its own, with 20 other manufacturers making up the rest. 2025 is the largest year on record at $6,206, more than ten times the $80 reported in 2022.
Across 60 payments — averaging $115.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$6K
- Astellas Pharma US Inc$257
- Minerva Surgical, Inc$133
- Hologic Sales And Service, LLC$76
- Exact Sciences$75
- AbbVie$73
- plus $446 from 15 others
What the payments were for
- Travel & lodging$1,25318%
- Food & beverage$1,15317%
- Education$4,50065%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 10 | $5,846 |
| Astellas Pharma US Inc | 16 | $257 |
| Minerva Surgical, Inc | 3 | $133 |
| Hologic Sales And Service, LLC | 1 | $76 |
| Exact Sciences | 4 | $75 |
| AbbVie | 4 | $73 |
| Organon | 3 | $59 |
| Shield Therapeutics Inc | 1 | $54 |
| Bayer | 3 | $51 |
| Exeltis, USA Inc. | 2 | $43 |
| Axonics, Inc. | 2 | $41 |
| Coloplast | 2 | $39 |
| Pfizer | 1 | $27 |
| Innovation Technologies Inc | 1 | $25 |
| Therapeuticsmd, Inc. | 1 | $20 |
| Agile Therapeutics, Inc. | 1 | $17 |
| Johnson & Johnson | 1 | $16 |
| Currax Pharmaceuticals LLC | 1 | $15 |
| Coopersurgical, Inc. | 1 | $15 |
| Solventum Corporation | 1 | $13 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAVINCI XI$4,500
- Da Vinci Surgical System$1,223
How this compares
$6,906 in reported general payments places this provider in the 60th percentile of 21 gynecologic oncology providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 38 | $2,364 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 12 | $60 |
| Oxybutynin Chloride | 12 | $46 |
Paid to pharmacies, not to this prescriber.
Other gynecologic oncology in Owasso
- Debra RichardsonOklahoma City$97K
- Daron StreetTulsa$55K
- Katherine MoxleyTulsa$44K
- Camille JacksonOklahoma City$35K
- Tara CastellanoOklahoma City$26K
- Michael GoldTulsa$15K
- Joan WalkerOklahoma City$11K
- Christina WashingtonOklahoma City$9K
- Elizabeth EvansOklahoma City$3K
- Lauren DockeryOklahoma City$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.